Gellert‐Kristensen, H., Richardson, T. G., Davey Smith, G., Nordestgaard, B. G., Tybjærg‐Hansen, A., & Stender, S. (2020). Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population. Hepatology (Baltimore, Md.), 72(3), 845-856. https://doi.org/10.1002/hep.31238
Chicago-Zitierstil (17. Ausg.)Gellert‐Kristensen, Helene, Tom G. Richardson, George Davey Smith, Børge G. Nordestgaard, Anne Tybjærg‐Hansen, und Stefan Stender. "Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population." Hepatology (Baltimore, Md.) 72, no. 3 (2020): 845-856. https://doi.org/10.1002/hep.31238.
MLA-Zitierstil (9. Ausg.)Gellert‐Kristensen, Helene, et al. "Combined Effect of PNPLA3, TM6SF2, and HSD17B13 Variants on Risk of Cirrhosis and Hepatocellular Carcinoma in the General Population." Hepatology (Baltimore, Md.), vol. 72, no. 3, 2020, pp. 845-856, https://doi.org/10.1002/hep.31238.